Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial
Banu Aygün, Adam Lane, Luke R. Smart, Brígida Santos, Léon Tshilolo, Thomas N. Williams, Peter Olupot‐Olupot, Susan E. Stuber, George Tomlinson, Teresa Latham, Russell E. Ware
Topics & Concepts
MedicineSickle cell anemiaOpen labelPediatricsAnemiaClinical trialInternal medicineDiseaseHemoglobinopathies and Related DisordersMyeloproliferative Neoplasms: Diagnosis and TreatmentBlood groups and transfusion